A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.

Christoph Abels Michael SoeberdtA KilicH ReichU KnieC JourdanK SchrammS Heimstaedt-MuskettClarissa Masur Rolf-Markus Szeimies

Published in: The British journal of dermatology (2021)

GPB 1% cream may provide an effective new treatment option exhibiting a good safety profile for patients with PAHH. The long-term open-label part (phase IIIb) is ongoing.

Keyphrases

randomized controlled trial
open label
study protocol
clinical trial
systematic review
combination therapy
radiation therapy
early stage
neoadjuvant chemotherapy
ultrasound guided
phase iii